LASA
Invest Now
Start SIP in
LASA
Performance
- Low
- ₹13
- High
- ₹13
- 52 Week Low
- ₹13
- 52 Week High
- ₹33
- Open Price₹13
- Previous Close₹13
- Volume237,492
Investment Returns
- Over 1 Month -30.76%
- Over 3 Month -41.12%
- Over 6 Month -53.64%
- Over 1 Year -47.03%
Smart Investing Starts Here Start SIP with Lasa Supergenerics for Steady Growth!
Lasa Supergenerics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -4.3
- PEG Ratio
- -0.1
- Market Cap Cr
- 63
- P/B Ratio
- 0.8
- Average True Range
- 1.01
- EPS
- 0.18
- Dividend Yield
- 0
- MACD Signal
- -1.06
- RSI
- 30.77
- MFI
- 19.01
Lasa Supergenerics Financials
Lasa Supergenerics Technicals
EMA & SMA
Current Price
₹12.56
-0.62
(-4.7%)

-
- Bearish Moving Average 16
-
- Bullish Moving Average 0
- 20 Day
- ₹14.64
- 50 Day
- ₹16.63
- 100 Day
- ₹19.07
- 200 Day
- ₹21.71
Resistance and Support
12.79
- R3 13.81
- R2 13.55
- R1 13.05
- S1 12.29
- S2 12.03
- S3 11.53
Lasa Supergenerics Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-05-28 | Audited Results | (Revised) per share(2.5%)Final Dividend |
2025-02-13 | Quarterly Results | |
2025-01-28 | Others | Inter-alia, to consider 1. The issue of warrants. 2. Proposal of fund raising by way of equity shares through rights issue. 3. Other business matters. per share(2.5%)Final Dividend |
2024-11-14 | Quarterly Results | |
2024-08-14 | Quarterly Results |
Lasa Supergenerics F&O
About Lasa Supergenerics
- NSE Symbol
- LASA
- BSE Symbol
- 540702
- Chairman & Managing Director
- Dr. Omkar Pravin Herlekar
- ISIN
- INE670X01014
Similar Stocks to Lasa Supergenerics
Lasa Supergenerics FAQs
Lasa Supergenerics share price is ₹12 As on 15 June, 2025 | 22:57
The Market Cap of Lasa Supergenerics is ₹62.9 Cr As on 15 June, 2025 | 22:57
The P/E ratio of Lasa Supergenerics is -4.3 As on 15 June, 2025 | 22:57
The PB ratio of Lasa Supergenerics is 0.8 As on 15 June, 2025 | 22:57
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.